Company: PFSA
Filing Date: 2025-10-29
Form Type: 424B3
Source: 0001213900-25-103174
Chunk: 307

Company: Profusa, Inc.
Filing Date: 2025-10-29
Form: 424B3
Chunk 307
---
 |   |
| Legal and accounting costs                                                                                                            |     |              |  1,223 |   |     |   |   2,287 |   |
| Other expenses(1)                                                                                                                     |     |              |    120 |   |     |   |     202 |   |
| Total segment expenses                                                                                                                |     |              |  4,600 |   |     |   |   6,115 |   |
| Loss from operations                                                                                                                  |     |              | (4,500 | ) |     |   |  (6,070 | ) |
| Other income (expenses)                                                                                                               |     |              |        |   |     |   |         |   |
| Loss on change in the fair value of related party Tasly convertible debt                                                              |     |              |   (311 | ) |     |   |     (22 | ) |
| Interest expense (including related parties amounts of $2,400 and $2,530 for the year ended December 31, 2024 and 2023, respectively) |     |              | (4,424 | ) |     |   |  (4,283 | ) |
| Other income                                                                                                                          |     |              |      5 |   |     |   |      94 |   |
| Total other expense, net                                                                                                              |     |              | (4,730 | ) |     |   |  (4,211 | ) |
| Net loss and comprehensive loss                                                                                                       |     | $            | (9,230 | ) |     | $ | (10,281 | ) |

| (1) | Other expenses includes small balances of research materials and supplies along with insurance costs. |

The Company has no significant
long-lived assets recognized on the Consolidated Balance Sheets.

Note 15 — Subsequent Events

The Company has evaluated
its subsequent events from December 31, 2024, through the date these consolidated financial statements were issued and has determined
that there are no subsequent events requiring disclosure in these consolidated financial statements other than the items noted below.

On various dates in February
and March 2025, the Company received an aggregate amount of $0.8 million from the issuance of Senior Secured Convertible Notes which are
expected to be converted in 2025 upon the closing of the Company’s Qualified Financing transaction. These subsequent notes issued
in 2025 are on similar terms as all other Senior Secured Convertible Notes in